420 LEXINGTON AVE,, NEW YORK, NY
Citius Oncology Approves Amendment to 2024 Omnibus Stock Incentive Plan
Corporate Overview October 2025
News, Material Contracts
Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
Other Events
Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update
Announces Closing of $9.0 Million Public Offering
Q2
Q1
Q4
Amended Annual Report
FY 2023
Notice of Late Filing for Quarterly Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Proxy Statement
Definitive Additional Proxy Soliciting Materials
Definitive Information Statement
Preliminary Information Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence